| dc.description |
<p>Cardiovascular (heart and vascular) diseases are today's anddeveloping leading causes of mortality (death) and morbidity (incapacity) incountries for a number of reasons. In addition, due to its direct or indirectcosts, health plays a major role in spending. In many European countries inrecent years, cardiovascular disease mortality rates are significantly lower. isdoing. Although it has decreased, it still remains the most important cause ofpremature death in Europe. More than 80% of cardiovascular disease deathsoccur in developing countries. It is estimated to occur (Narla et al. 2009, Uyar2009, Perk et al. 2012). In the decreasing trend of cardiovascular disease indeveloped countries, the behavior of society's conservation programs aimed atchange has had an impact. Studies have shown that an unhealthy lifestyle andsocial environment are the basis of cardiovascular diseases. (Arıkan et al.2009).Cholesterol is divided into two types: Our health depends on thepresence of benign cholesterol (HDL), which is important in the body andshould have high levels. HDL helps excess cholesterol in our bodies reach theliver, where it is processed and excreted through the digestive system. HDL isknown as "good cholesterol" because it slows blood circulation and eliminatescholesterol from the body that causes vascular blockage. On the other hand,malignant cholesterol (LDL) is a protein that is generated in the liver andcarried through the bloodstream. LDL has various positive qualities inaddition to being well-known. When LDL (Güven A., 2005), which transportsantioxidants and amino acids to other cells, is detected in excess in the humanbody, it has a deleterious impact on the body. As a result, diagnosis andtherapy are critical. Drugs like ezetimibe and simvastatin are used to treat thecondition. As a result, atorvastatin and ezetimibe concentrations must bedetermined. UV spectroscopy data was used to make chemometricmeasurements of cholesterol medications in this research.<br></p> |
|